SCHEMBL16632999

SCHEMBL16632999

FC(F)(F)c1nc2ccc(Br)cc2c(Cl)c1Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
NT5E P21589 1/20 0.48
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
RORC P51449 3/20 0.37
PTGFR P43088 3/20 0.37
PDE5A O76074 2/20 0.37
PLA2G2A P14555 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16633125 0.85 NT5E (0.42) CYP1A2CYP2D6CYP2C9CYP2C19NT5E
SCHEMBL16632627 0.85 CCNC (0.41) CCNCCDK8RORCPTGFRPLA2G2A
SCHEMBL16633300 0.84 MAOA (0.46) KMT2AMAPTKDM4EALDH1A1GAA
SCHEMBL12749514 0.82 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C9CYP2C19RXFP1
SCHEMBL15647927 0.79 RORC (0.47) CYP1A2CYP2D6CYP2C9CYP2C19RXFP1
SCHEMBL15647597 0.77 ENPP1 (0.54) CYP1A2CYP2D6CYP2C9CYP2C19RXFP1
SCHEMBL12749518 0.77 CYP1A2 (0.51) CYP1A2CYP2D6CYP2C9CYP2C19RXFP1
SCHEMBL16462100 0.77 CYP1A2 (0.61) CYP1A2CYP2D6CYP2C9CYP2C19RXFP1
SCHEMBL15648267 0.75 CYP1A2 (0.52) CYP1A2CYP2D6CYP2C9CYP2C19RXFP1
SCHEMBL28250228 0.75 NT5E (0.41) RXFP1NT5ECCNCCDK8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057951-B1 METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T JANSSEN PHARMACEUTICA NV (BE) 2019-11-20 EP disclosed
EP-3057951-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T Janssen Pharmaceutica N.V. (BE) 2016-08-24 EP disclosed
US-9284308-B2 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 2016-03-15 US disclosed
US-9284308-B2 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 2016-03-15 US disclosed
WO-2015057205-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T JANSSEN PHARMACEUTICA NV (BE) 2015-04-23 WO disclosed
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt RORC, RORA, RORB CYP1A2 841/4885CYP2D6 321/4885CYP2C9 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.